ACORN HOLDING CORP
DEF 14A, 2000-10-30
Previous: IMMUCOR INC, DEFR14A, 2000-10-30
Next: FUTUREFUNDS SERIES ACCOUNT OF GREAT WEST LIFE & ANN INS CO, 485BPOS, 2000-10-30



                                  SCHEDULE 14A
                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION

           Proxy Statement Pursuant to Section 14(a) of the Securities
                      Exchange Act of 1934 (Amendment No. )

Filed by the Registrant [x]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ]  Preliminary Proxy Statement          [ ] Confidential, For Use of
                                              the Commission Only (as
                                              permitted by Rule 14a-6(e)(2))
[x]  Definitive Proxy Statement
[ ]  Definitive Additional Materials

[ ]  Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

                               ACORN HOLDING CORP.

       -----------------------------------------------------------------
                (Name Of Registrant As Specified In Its Charter)

-----------------------------------------------------------------
Name Of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check appropriate box):

         [X]  No fee required.
         [ ]  Fee computed on table below per Exchange Act Rules  14a-6(i)(1)
              and 0-11.

         (1)    Title of each class of securities to which transaction applies:

        -----------------------------------------------------------------

         (2)      Aggregate number of securities to which transaction applies:

        -----------------------------------------------------------------
         (3)      Per  unit  price  or other  underlying  value  of  transaction
                  computed  pursuant  to  Exchange  Act Rule 0-11 (set forth the
                  amount on which filing fee is calculated  and state how it was
                  determined):

        -----------------------------------------------------------------

         (4)      Proposed maximum aggregate value of transaction:

        -----------------------------------------------------------------

         (5)      Total fee paid:

        -----------------------------------------------------------------

         [ ]      Fee paid previously with preliminary materials:

        -----------------------------------------------------------------

         [ ]      Check box if any part of the fee is offset  as  provided  by
                  Exchange Act Rule 0-11(a)(2) and identify the filing for which
                  the offsetting fee was paid previously.  Identify the previous
                  filing  by  registration  statement  number,  or the  form  or
                  schedule and the date of its filing.

         (1)      Amount Previously Paid:

        -----------------------------------------------------------------

         (2)      Form, Schedule or Registration Statement no.:

        -----------------------------------------------------------------

         (3)      Filing Party:

        -----------------------------------------------------------------

         (4)      Date Filed:

        -----------------------------------------------------------------


<PAGE>
                               ACORN HOLDING CORP.

                           1251 Avenue of the Americas

                                   45th Floor

                          New York, New York 10020-1104

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

                          To Be Held December 12, 2000

To the Stockholders:

         The Annual  Meeting of the  Stockholders  of ACORN HOLDING  CORP.  (the
"Company")  will be held at 1251 Avenue of the Americas,  45th Floor,  New York,
New York,  on Tuesday,  December 12, 2000,  at 11:00 A.M.,  local time,  for the
following purposes:

         1. To elect five directors to hold office until the next Annual Meeting
of Stockholders and until their respective successors have been duly elected and
qualified;

         2. To ratify the  selection  of the firm of Grant  Thornton  LLP as the
independent public accountants of the Company for the 2000 fiscal year; and

         3. To  transact  such other  business as may  properly  come before the
meeting or any adjournment(s) thereof.

         The Board of  Directors  has fixed the close of business on October 26,
2000,  as the record  date for the  determination  of  stockholders  entitled to
notice of, and to vote at, the Annual Meeting of Stockholders  (the  "Meeting").
Only  stockholders  of  record  at the  close of  business  on this date will be
entitled to notice of, and to vote at, the Meeting or any adjournment thereof.

                                            By Order of the Board of Directors

                                            STEPHEN A. OLLENDORFF
                                            Secretary

October 27, 2000

         YOU ARE URGED TO COMPLETE,  DATE AND SIGN THE ENCLOSED PROXY AND RETURN
IT PROMPTLY IN THE POSTAGE PREPAID ENVELOPE WHICH HAS BEEN PROVIDED,  WHETHER OR
NOT YOU PLAN TO ATTEND THE MEETING IN PERSON. THE PROXY MAY BE REVOKED BY YOU AT
ANY TIME PRIOR TO  EXERCISE,  AND IF YOU ARE  PRESENT AT THE MEETING YOU MAY, IF
YOU WISH,  REVOKE YOUR PROXY AT THAT TIME AND  EXERCISE  YOUR RIGHT TO VOTE YOUR
SHARES PERSONALLY.


<PAGE>

                                 PROXY STATEMENT

                               ACORN HOLDING CORP.
                           1251 Avenue of the Americas
                                   45th Floor
                          New York, New York 10020-1104

                         Annual Meeting of Stockholders
                          To Be Held December 12, 2000

                               GENERAL INFORMATION

         This proxy statement is furnished in connection  with the  solicitation
of proxies by the Board of Directors of Acorn Holding Corp.  (the "Company") for
use at the 2000 Annual  Meeting of  Stockholders  (the  "Meeting") to be held at
1251 Avenue of Americas,  45th Floor,  New York, New York, on Tuesday,  December
12, 2000, at 11:00 A.M., local time, and at any  adjournment(s)  thereof for the
purposes set forth in the accompanying Notice of Meeting of Stockholders.

         The  principal  executive  offices of the  Company  are located at 1251
Avenue of the Americas, 45th Floor, New York, New York 10020-1104 (telephone no.
212-536-4089). The enclosed proxy and this proxy statement are being transmitted
to stockholders of the Company on or about October 30, 2000.

Voting Securities; Solicitation and Revocation
----------------------------------------------

         The  Company's  Board of  Directors  has fixed the close of business on
October 26, 2000, as the record date for the  determination  of  stockholders of
the Company who are entitled to receive  notice of, and to vote at, the Meeting.
At the close of business on that date,  1,627,358  shares of Common  Stock,  par
value $.01 (the "Common Stock"),  were issued and outstanding,  each of which is
entitled  to one vote on each  matter to be voted  upon at the  Meeting.  Unless
otherwise indicated, all of the shares of the Common Stock have been adjusted to
reflect the  two-for-five  reverse stock split,  effective  April 19, 1999.  The
Company has no other class of securities entitled to vote at the Meeting.

         Proxies in the form  enclosed are being  solicited by, or on behalf of,
the Board of Directors.  The persons named in the proxy have been  designated as
proxies in  respect of the  Meeting by the  Company's  Board of  Directors  (the
"Board").  Pursuant to Delaware  corporate  law and the Company's  By-laws,  the
holders of a majority of the outstanding  shares of Common Stock must be present
in person or  represented  by proxy for a quorum to exist at the  Meeting.  If a
quorum is present at the Meeting,  the nominees for director shall be elected by
a  plurality  of the votes  present  (in person or by proxy) at the  Meeting and
entitled  to vote  thereon.  The  approval  of all other  matters to be properly
brought by the Board of Directors before the Meeting  (assuming a quorum exists)
requires  the  affirmative  vote of the  holders of a majority  of the shares of
Common Stock present (in person or by proxy) at the Meeting and entitled to vote
thereon.

<PAGE>
         Abstentions  and  broker  non-votes  (i.e.,   shares  of  Common  Stock
represented  at the  Meeting by proxies  held by brokers or nominees as to which
(i)  instructions  have not been received from the beneficial  owners or persons
entitled  to vote and (ii) the  broker or  nominee  does not have  discretionary
voting  power on a  particular  matter)  with  respect to any  proposal  will be
included  in  determining  the  existence  of a quorum.  Abstentions  and broker
non-votes  will not be counted in  tabulations  of the votes cast on  proposals.
Thus,  neither  abstentions  nor  broker  non-votes  will  have an effect on the
outcome of the election of the nominees for  directors,  which  requires  only a
plurality of the votes at the Meeting,  or of the  ratification of the selection
of the independent  accountants,  which requires only the affirmative  vote of a
majority  of the shares of Common  Stock  present (in person or by proxy) at the
Meeting in favor of such proposal.

         Shares represented by properly executed proxies received by the Company
will  be  voted  at the  Meeting  in the  manner  specified  therein  or,  if no
specification  is made,  will be voted "FOR" the election of all of the nominees
for directors named herein,  and "FOR" the  ratification of the selection of the
firm of Grant Thornton LLP as the Company's  independent  public accountants for
the 2000 fiscal  year.  In the  unanticipated  event that any other  matters are
properly  presented  at the Meeting for action,  the persons  named in the proxy
will vote the  proxies  (which  confer  authority  upon them to vote on any such
matters) in accordance with their judgment.

         Any proxy  given  pursuant  to this  solicitation  may be  revoked by a
stockholder  at any time  before  it is voted by  written  notification  thereof
delivered to Messrs.  Edward N. Epstein  and/or Stephen A.  Ollendorff  (Company
Secretary),  c/o of the Company at the address set forth hereinabove,  by voting
in person at the Meeting, or by executing and delivering another proxy bearing a
later date.  Attendance by a stockholder  at the Meeting does not alone serve to
revoke his or her proxy.

         The  solicitation  of proxies will be made  principally by mail and, in
addition,  may be made by directors and officers of the Company personally or by
telephone or telegraph, without special or extra compensation for such services.
Arrangements  will be made with brokerage firms and other  custodians,  nominees
and fiduciaries to forward proxies and proxy material to their  principals,  and
the Company  will,  upon request,  reimburse  them for their  out-of-pocket  and
clerical  expenses in  transmitting  proxies and related  material to beneficial
owners.  The costs of  soliciting  proxies will be borne by the  Company.  It is
estimated that said costs will be relatively nominal.

Annual Report
-------------

         The  Company's  Annual  Report for the fiscal year ended  December  31,
1999, which contains  audited  financial  statements,  is being mailed with this

                                       2
<PAGE>

Proxy  Statement  to all  Company  stockholders  of  record  as of the  close of
business on October 26, 2000.

                    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
                              OWNERS AND MANAGEMENT

         The following  table sets forth, as of the close of business on October
26,  2000,  information  as to  the  stockholders  (other  than  members  of the
Company's  management),  which are known by the Company to beneficially own more
than 5% of its Common Stock.

                                 No. of Shares
Name and Address                 Beneficially                   Percentage
of Beneficial Owner               Owned(1)                       of Class
-------------------               --------                       --------

Estate of Herbert Berman(2)        113,440                         7.0%
 405 Lexington Avenue
 New York, NY 10174

Allen Landers, M.D.
1385 York Avenue
New York, NY 10021                 101,520                         6.3%

---------------
(1)       Beneficial  ownership,  as  reported  in the  above  table,  has  been
          determined in accordance with Rule 13d-3 under the Securities Exchange
          Act of 1934 (the "1934 Act"). Such beneficial  ownership includes both
          sole voting and sole dispositive power.

(2)       Excludes shares of Common Stock owned by the adult children of the
          late Herbert Berman.

Ownership by Management
-----------------------

          The following table sets forth, as of October 26, 2000, the beneficial
ownership of the Common  Stock of the Company by (i) each  present  director and
nominee for election as a director of the Company, (ii) the Named Executives, as
defined below, and (iii) all directors and executive  officers of the Company as
a group (based upon information  furnished by such persons).  Under the rules of
the Commission,  a person is deemed to be a beneficial owner of a security if he
has or shares  the power to vote or direct the  voting of such  security  or the
power to dispose or direct the disposition of such security.  Accordingly,  more
than one person may be deemed to be a beneficial owner of the same securities. A
person is also deemed to be a beneficial  owner of any  securities of which that
person has the right to acquire beneficial ownership within 60 days.

                                       3
<PAGE>

                                      No. of Shares
Name and Address                      Beneficially                   Percentage
of Beneficial Owner(1)                 Owned(2)                       of Class
----------------------                -------------                  ----------

Bert Sager..............               171,250(3)(4)                  10.12%

Stephen A. Ollendorff...               608,680                        34.83%
                                       (4)(5)(6)

Edward N. Epstein.......               385,800(4)(5)(7)               23.03%

Paula Berliner..........                67,320(4)                      4.07%

Robert P. Freeman.......                56,000(4)                      3.36%

Ronald J. Manganiello...                62,278(8)                      3.83%


All directors and executive
 officers as a group
 (7 persons)...........              1,033,456(4)                     52.64%


-----------
*     Less than 1%.

(1)      The business  address,  for purposes  hereof,  of all of the  Company's
         directors and executive officers is in care of the Company's  principal
         executive offices at 1251 Avenue of the Americas, 45th Floor, New York,
         New York 10020-1104.

(2)      Beneficial  ownership,  as  reported  in  the  above  table,  has  been
         determined  in  accordance  with Rule 13d-3 under the 1934 Act.  Unless
         otherwise  specifically  noted  herein,  the Company  believes that all
         persons in the above table have sole voting and dispositive  power with
         respect to all shares of Common Stock shown to be beneficially owned by
         them.

(3)      Does not include 80 shares of Common Stock owned by Marilyn Sager, his
         wife, with respect to which Mr. Sager disclaims beneficial ownership.

(4)      Includes the following shares that may be acquired upon the exercise of
         options  within 60 days of October 26, 2000:  Mr.  Sager - 64,000;  Mr.
         Ollendorff - 120,000;  Mr. Epstein - 48,000; Ms. Berliner - 28,000; Mr.
         Freeman - 40,000;  and all directors and executive  officers as a group
         (7 persons) - 336,000.

(5)      Stephen A.  Ollendorff,  the Company's  Chief  Executive  Officer,  has
         entered into an Irrevocable  Proxy and Voting Agreement With Respect to
         Election of Directors, dated December 19, 1995, with Edward N. Epstein,
         the Company's  President,  with respect to the 385,800 shares of Common
         Stock beneficially owned by Mr. Epstein.  This arrangement is described
         in "Certain Relationships and Related Transactions."  Accordingly,  Mr.
         Ollendorff's  beneficial  ownership includes such shares. Other than as
         set forth above, Mr. Ollendorff  disclaims beneficial ownership of such
         shares.

                                       4
<PAGE>

(6)      Includes 400 shares owned by Bjorg Ollendorff, Mr. Ollendorff's wife.

(7)      Includes shares owned by Mr. Epstein as trustee for his minor child.

(8)      Includes  2,278  shares  owned  of  record  by  Lisa  Manganiello,  Mr.
         Manganiello's wife.

                     PROPOSAL I: ELECTION OF FIVE DIRECTORS

         The entire  Board of  Directors  is to be elected at the  Meeting.  The
Company's  By-laws  provide  that the number of directors  comprising  the Board
shall be at least one, such number to be fixed by  resolution of the Board.  The
number of directors is presently set at five. The five persons listed below, all
of whom have consented to being named in this Proxy  Statement and to serving if
elected,  have been  nominated to serve as  directors  of the Company  until the
Company's  2001  annual  meeting  of  stockholders  and until  their  respective
successors  have  been duly  elected  and  qualified.  All of the  nominees  are
currently  directors  of the  Company,  and each was  elected  by the  Company's
stockholders at the last annual meeting of stockholders.

         Proxies in the accompanying  form will be voted at the Meeting in favor
of the election of each of the nominees listed below,  unless authority to do so
is specifically withheld as to an individual nominee or nominees or all nominees
as a group.  Proxies  cannot be voted for a greater  number of persons  than the
number of nominees  named.  In the  unexpected  event that any of such  nominees
should become  unable to or for good cause will not serve,  the persons named in
the accompanying proxy have  discretionary  authority to select and vote for the
election  of  substitute  management  nominees.  Directors  will be elected by a
plurality of the votes present at the Meeting in person or by proxy and entitled
to vote thereon.

         Set forth below is certain information with respect to each nominee for
election as a director of the Company (based solely on  information  provided by
such nominees):

                           Year of              Principal Occupations During
                            First                    Past Five Years;
Name and Age               Election                Other Directorships

Bert Sager(1)(2)             1983                Co-Chairman of the Board of the
(75)                                             from  November 1995 to December
                                                 1998  and  Chairman  from  June
                                                 1989  to  November  1995;  from
                                                 inception   until   June  1989,
                                       5
<PAGE>
                                                 President;  for  more  than the
                                                 past five years,  a  practicing
                                                 attorney;  director  of Artesyn
                                                 Technologies,       Inc.      a
                                                 manufacturer   of  standardized
                                                 electronic products.

Stephen A.                                       Chief  Executive  Officer since
  Ollendorff                                     September 1992, and Chairman of
(62)(1)                     1983                 the Board since  November 1995;
                                                 President  of the Company  from
                                                 June 1989 until  November  1995
                                                 and   Vice    President    from
                                                 inception until his election as
                                                 President;  Of  Counsel  to the
                                                 law firm of Hertzog, Calamari &
                                                 Gleason  from   December   1990
                                                 until   January   1999;   since
                                                 February  1999,  Of  Counsel to
                                                 the law firm of  Kirkpatrick  &
                                                 Lockhart   LLP.   Director   of
                                                 Artesyn Technologies,  Inc. and
                                                 Pharmaceutical Resources, Inc.,
                                                 a   manufacturer   of   generic
                                                 drugs.

Edward N. Epstein*         1995                  President  and Chief  Operating
(60)(1)                                          Officer  of the  Company  since
                                                 November  1995.  For more  than
                                                 the   past   five   years,    a
                                                 principal  of Edward N. Epstein
                                                 &  Assoc.,  a  consulting  firm
                                                 specializing    in    corporate
                                                 structuring   and   management;
                                                 since January 1996, a principal
                                                 in the merchant banking firm of
                                                 New Canaan  Capital LLC;  since
                                                 July  1996,   a  principal   of
                                                 Sylhan   LLC,   an   integrated
                                                 contract           manufacturer
                                                 specializing  in the  precision
                                                 machining of  refractory  metal
                                                 parts.

Paula Berliner             1992                  Vice President of the Company
(57)(1)(2)                                       since June 1992 until  December
                                                 1998;  since May 1990,  private
                                                 investor;  director of Republic
                                                 Security   Financial  Corp.,  a
                                                 holding  company  for  Republic
                                                 Security Bank.

Ronald J. Manganiello*     1995                  Since January 1996, a principal
(51) (1)(2)                                      in the merchant banking firm of
                                                 New Canaan  Capital LLC;  since
                                                 July  1996,   a  principal   of
                                                 Sylhan   LLC;   from   1986  to
                                                 January 1996,  Mr.  Manganiello
                                                 was    Chairman    and    Chief
                                                 Executive   Officer  of  Hanger
                                                 Orthopedic   Group,   Inc.,   a
                                                 publicly-traded   provider   of
                                                 patient   care   services   and
                                                 products   for   orthotic   and
                                                 prosthetic rehabilitation.

----------
*  Designees for directors of Edward N. Epstein.  See "Certain
   Relationships and Related Transactions."

                                       6
<PAGE>

(1)  Member of the Stock Option and Compensation Committee.

(2)  Member of the Audit Committee.

(3)  Mr. Manganiello was a member of the Board from November 1995 until January
     1997 and was then  elected  to the Board in December 1997.


         THE BOARD UNANIMOUSLY  RECOMMENDS A VOTE "FOR" THE ELECTION OF THE FIVE
NOMINEES NAMED ABOVE AS DIRECTORS OF THE COMPANY.

Board of Directors; Committees of the Board
-------------------------------------------

         The Board met three times during  fiscal 1999.  During  fiscal 1999, no
director  attended  fewer than 75% of the total  number of meetings of the Board
and of the  committees  of  the  Board  on  which  he  served,  other  than  Mr.
Manganiello and Ms. Berliner who each attended one meeting.

         The Board has  established two standing  committees,  consisting of the
Audit  Committee and the Stock Option and  Compensation  Committee.  The current
functions of such committees are as follows:

         The Audit Committee, which did not meet during fiscal 1999, reviews the
internal and external audit  functions of the Company and makes  recommendations
to the Board with respect thereto.  It also has primary  responsibility  for the
formulation  and  development  of the auditing  policies and  procedures  of the
Company  and  for  making  recommendations  to the  Board  with  respect  to the
selection  of the  Company's  independent  auditing  firm.  The Chairman of this
Committee is Ronald J. Manganiello.

         The Stock Option and Compensation Committee,  which did not meet during
fiscal 1999, has primary  responsibility for the administration of the Company's
1991 Stock Option  Plan,  including  responsibility  for the granting of options
thereunder.  The  Committee is also  responsible  for  establishing  the overall
philosophy of the Company's  executive  compensation  program and overseeing the
Company's  compensation  strategy. In fiscal 1999, the members of this Committee
consisted of the entire Board of Directors.

Section 16(a) Compliance
------------------------

         The Company is aware of the following  late filing of reports  required
by Section  16(a) of the 1934 Act in respect of fiscal  1999:  Edward N. Epstein
failed  to file,  on a timely  basis,  a  Statement  of  Changes  in  Beneficial
Ownership on Form 4. This filing was  subsequently  completed on the appropriate
form.

Compensation of Directors
-------------------------

         Effective  December 1998,  directors who are not executive  officers of
the Company are  compensated for their services by payment of an annual retainer
of  $12,000,  $1,000 per day for each Board  meeting  attended in person by such
director  and  $750  for each  committee  meeting  attended  in  person  by such

                                       7
<PAGE>

director.  Mr.  Sager and Mrs.  Berliner  are each  entitled as  consultants  to
receive $24,000 per year,  including  directors  fees, for a minimum  three-year
period, which has been renewed by its terms.

Certain Relationships and Related Transactions
----------------------------------------------

         Mr. Ollendorff,  Chief Executive Officer of the Company, was of counsel
to Hertzog,  Calamari & Gleason, general counsel to the Company, through January
31, 1999.  Effective February 1, 1999, the Company no longer retains counsel who
are affiliated with Mr. Ollendorff.

         Mr.  Ollendorff  has  entered  into an  Irrevocable  Proxy  and  Voting
Agreement With Respect to Election of Directors  (the  "Proxy"),  with Edward N.
Epstein,  with respect to the shares of Common Stock  beneficially  owned by Mr.
Epstein  (the  "Stock"),  commencing  on December  19, 1995 and  terminating  on
December 31 of such year in which  either party shall have given the other party
at least twelve (12) months' written notice thereof prior to December 31 of such
year.  If any  shares  of the Stock  covered  by the Proxy are sold to any other
party,  the  Proxy  as it  relates  to such  shares  of  Stock  shall  terminate
immediately upon such sale. Pursuant to the Proxy, Mr. Ollendorff  undertakes to
vote the Stock,  as well as use his best  efforts  (including  voting  shares of
stock of the  Company  owned by him) for the  election of the greater of (i) two
(2) directors or (ii) a number of directors equal to 22% (rounded up to the next
highest number) of the entire Board of Directors, acceptable to Mr. Epstein. Mr.
Epstein had designated  himself and Ronald J. Manganiello to Mr. Ollendorff with
respect to the election of members of the Board as acceptable to him.

Executive Officers
------------------

         The  executive  officers of the Company  consist of Mr.  Ollendorff  as
Chairman of the Board,  Chief Executive Officer and Secretary,  Mr. Epstein,  as
President and Chief Operating Officer, and Larry V. Unterbrink as Treasurer.

         The following table sets forth certain  information with respect to the
executive  officer of the Company who is not a director or nominee for  election
as a director:

Name                                                     Age
----                                                     ---

Larry V. Unterbrink..........................            66
         Treasurer of the Company since February
         1990; director from 1985 until February
         1995.  Private investor residing in Florida.
         Since November 1996, a principal of Groupe
         Financier, a publishing and consulting firm
         specializing in international finance.

                                       8
<PAGE>

                             EXECUTIVE COMPENSATION

Summary Compensation Table
--------------------------

         The following  table sets forth  information for the fiscal years ended
December  31, 1999,  December  31, 1998 and  December  31,  1997,  respectively,
respecting compensation earned by the Chief Executive Officer of the Company and
the  executive  officers  (whose salary and bonus earned in fiscal 1999 exceeded
$100,000)  of  the  Company  serving  at the  end of  fiscal  1999  (the  "Named
Executives").

                                       Annual Compensation(1)      Long-Term
                                                                  Compensation
                                       ----------------------     -------------
                                                                    Securities
     Name and                                                       Underlying
 Principal Position        Year       Salary($)     Bonus($)      Options(#)(2)
  ------------------       ----       ---------     --------      -------------

  Stephen A. Ollendorff    1999(3)     $250,543(4)                      --
    Chairman and Chief     1998(3)     $246,597        -0-
    Executive Officer      1997(3)     $254,615(5)     -0-            50,000



  Edward N. Epstein        1999        $216,192(4)

  Robert P. Freeman        1999        $203,353      $ 50,000           --
    President and Chief    1998        $197,830      $ 50,000           --
    Executive Officer -    1997        $215,920      $ 95,673         50,000
    Recticon Enterprises,
    Inc.

(1)   No officer received perquisites which, are in the aggregate, greater than
      or equal to the lesser of $50,000 or 10% of annual salary and bonus.

(2)   Represents options awarded under the 1991 Stock Option Plan.

(3)   Mr.  Ollendorff  has  voluntarily  assumed  responsibility  for rent and
      secretarial  expenses  relating to the New York office.  Mr.  Ollendorff
      does not receive any fringe benefits from the Company.

(4)   Effective  November,  1999  Messrs.  Ollendorff  and  Epstein  voluntarily
      reduced by 50% their cash compensation received from the Company. Includes
      the unpaid  balance of $29,879  and $18,016  for  Messrs.  Ollendorff  and
      Epstein,  respectively,  reflecting the amounts being accrued on the books
      of the Company.

(5)   As a result of an agreement between Messrs.  Epstein and Ollendorff,  Mr.
      Ollendorff  voluntarily  reduced  his  annual  compensation  by  $24,280,
      effective  July  1997,  in  order  to  increase  Mr.   Epstein's   annual
      compensation for 1997 by $24,280. See "Employment Arrangements" below.

                                       9
<PAGE>

         The Company does not have any annuity, retirement, pension, deferred or
incentive  compensation plan or arrangement  under which any executive  officers
are entitled to benefits, nor does the Company have any long-term incentive plan
pursuant to which  performance  units or other forms of  compensation  are paid.
Executives  who qualify are permitted to participate in the Company's 1991 Stock
Option Plan.

Stock Option Grants In Last Fiscal Year
---------------------------------------

         During the fiscal year ended  December  31,  1999,  there were no stock
option grants or stock  appreciation  rights granted to the Named  Executives or
any other stock appreciation rights.

         On March 2, 1998 the Stock Option and Compensation Committee authorized
the further  amendment to certain of the  Company's  outstanding  stock  options
(which had previously  been amended on November 22, 1994).  In exchange for each
optionee agreeing to an increase in the exercise price in the event of a "change
of control" from, after adjusting to reflect the reverse split,  $1.406 to $3.13
(equal to the "fair  market  value" of the  Company's  Common  Stock on March 2,
1998), the Company would expand the definition of "change of control" to include
the merger,  sale or liquidation of the business as set forth in (iv) below. The
amended  and  expanded  definition  of "change of  control"  would  occur in the
following  circumstances:  (i) the first purchase of shares of equity securities
of the Company pursuant to a tender offer or exchange offer (other than an offer
by the Company) for 25% or more of the equity  securities of the Company,  which
offer has not been approved by the Board of the Company, (ii) a single purchaser
or a group of associated purchasers  acquiring,  without the approval or consent
of the Board of the Company,  securities of the Company representing 25% or more
of the combined voting power of the Company's then outstanding securities in one
or a  related  series  of  transactions,  (iii) in  respect  of an  election  of
directors  by the  Company's  stockholders,  the  election  of any or all of the
management's  slate of directors being  contested or opposed,  whether through a
solicitation of proxies,  or otherwise,  or (iv) on the day the  stockholders of
the Company approve (A) a definitive  agreement for the merger or other business
combination  of the Company with or into another  corporation  pursuant to which
the stockholders of the Company do not own,  immediately  after the transaction,
more than 50% of the voting  power of the  corporation  that  survives  and is a
publicly owned corporation and not a subsidiary of another corporation, or (B) a
definitive  agreement for the sale,  exchange,  or other  disposition  of all or
substantially all of the assets of the Company,  or (C) any plan or proposal for
the  liquidation or dissolution of the Company.  As of October 26, 2000, no such
"change of control" has occurred.

         On November 7, 1996,  the Board of Directors  authorized the Company to
loan moneys to officers and employees of the Company in order to encourage  them
to exercise their stock options. The term of such loans would be for the shorter
of ten years or 60 days  after  termination  of  employment  of the  officer  or
employee,  interest would accrue and be payable monthly on the principal, at the
prevailing  rate  applicable  to 90-day  treasury  bills at the time the loan is
made,  and the loan  would be  collateralized  at all  times,  which  collateral

                                       10
<PAGE>

(subject to applicable law) may include shares of the Company. The loans must be
collateralized  so that the fair market  value of the  collateral  would have to
equal or exceed the principal outstanding amount of the loan at all times. As of
October 26, 2000,  no such loans to officers or employees  have been made by the
Company.

Year-End Option Values Table
----------------------------

        The  following  table  sets  forth  information  at  December  31,  1999
respecting exercisable and non-exercisable options held by the Named Executives.
During fiscal 1999, the Named Executives did not exercise any stock options. The
table also includes the value of  "in-the-money"  stock options which represents
the spread  between the exercise  prices of the existing  stock  options and the
year-end price of the Common Stock.

                  Number of Unexercised         Value of Unexercised In-
                     Options Held                 the-Money Options
                 at December 31, 1999(1)       Held at December 31, 1999(1)
                 -----------------------       ----------------------------
                                   Not                            Not
Name             Exercisable    Exercisable     Exercisable    Exercisable
----             -----------    -----------     -----------    -----------

Stephen A.
  Ollendorff        120,000         -0-            $-0-             $-0-

Edward N.
  Epstein            48,000         -0-            $-0-             $-0-

Robert P.
  Freeman            40,000         -0-            $-0-             $-0-

----------------
(1) Based upon the closing  sales price of the Common Stock on December 31, 1999
($1.75).

Employment Arrangements
-----------------------

          The Company has entered into an  employment  agreement,  for a minimum
three-year  period,  which  has been  renewed  by its  terms,  with  Stephen  A.
Ollendorff,  pursuant to which Mr.  Ollendorff  receives annual  compensation of
$250,000,  subject to annual  cost-of-living  adjustments,  from the Company. On
January 17, 1996, Mr. Ollendorff's  employment agreement was amended in order to
clarify certain terms and conditions, including the geographic location in which
services are to be provided,  events of  termination  and his  obligations  with
respect to confidential information, non-solicitation of employees and covenants
not to compete.  Mr.  Ollendorff  agrees to devote such time to the business and
affairs of the Company as he believes is  necessary  for the  operations  of the
Company. In addition,  Mr. Ollendorff has voluntarily assumed responsibility for
rent and  secretarial  expenses  relating to the Company's New York office.  Mr.
Ollendorff receives no fringe benefits from the Company.

          Effective  January  1,  1997,  Mr.  Ollendorff  receives  a salary  of
$120,000  per year as  Chairman  of the  Board  of  Recticon  Enterprises,  Inc.
("Recticon"),  which  amount is paid by the  Company  from the  amounts  paid by
Recticon to the Company each month. In addition,  Recticon rents office space in

                                       11
<PAGE>

Mr.  Ollendorff's  New Jersey  office and pays rent  directly to Mr.  Ollendorff
directly for such space in the amount of $500 per month. Any amounts received by
Mr.  Ollendorff from Recticon as rent and/or salary are deducted from his salary
from the  Company to the  extent and as long as he  receives  such  monies  from
Recticon.

          The  Company  entered  into an  employment  agreement  with  Edward N.
Epstein,  effective  January 1, 1996,  for a three  year  period,  for an annual
compensation of $150,000,  subject to  cost-of-living  adjustments.  Mr. Epstein
agrees to devote  such time to the  business  and  affairs of the  Company as he
believes is necessary for the operations of the Company.

         As a result of an agreement between Messrs. Epstein and Ollendorff, Mr.
Ollendorff  voluntarily  reduced his annual  compensation by $24,280,  effective
July 1997, in order to increase Mr.  Epstein's  annual  compensation for 1997 by
$24,280.  Mr.  Ollendorff  has agreed not to accept any  increased  compensation
(other than  cost-of-living  increases) until Mr. Epstein's annual  compensation
shall be equal to Mr. Ollendorff's.

         Robert P. Freeman,  President and Chief Executive  Officer of Recticon,
entered into a letter  agreement  with  Recticon as of February 15, 1995,  which
provides  that if,  within one (1) year of a "change of control"  (as defined in
the  agreement)  of Recticon,  his  employment  is  terminated  without cause by
Recticon, or he resigns because of (i) assignment,  without his written consent,
of any duties  inconsistent  with his  position,  duties,  responsibilities  and
status with  Recticon,  or change in his  reported  responsibilities,  titles of
offices or any plan, act, scheme or design to  constructively  terminate him, or
(ii)  reduction  by  Recticon of his annual base  salary,  he shall  receive the
following benefits: (i) annual base salary through the date of termination; (ii)
in lieu of any further salary payments,  severance pay on the tenth business day
following the date of termination, a lump sum equal to two times his annual base
salary; and (iii) if Mr. Freeman terminates his employment with Recticon between
the first and second year of a change of control for any reason  other than "for
cause",  Recticon  will pay him the  amount  he would  have  been paid if he had
remained employed through the end of the second year of a change of control, but
in no event less than an amount equal to six months of base salary. In addition,
Recticon  will maintain all medical,  health and accident  plans for a period of
the  earlier  of (i) 24 months or (ii) the date of which he is covered by reason
of his being employed by a new employer. In addition,  the Board of Directors of
Recticon  authorized an annual bonus to Mr. Freeman equal to 5% of the operating
profit of Recticon, prior to the payment of bonuses and without giving effect to
the account supply commitment fees,  corporate charges,  executive  compensation
and consulting fees, but not less than $50,000 through the year 2000.

                     PROPOSAL II: RATIFICATION OF SELECTION
                             OF INDEPENDENT AUDITORS

          The  Board  has  selected  the  firm of  Grant  Thornton  LLP  ("Grant
Thornton"),  independent  certified  public  accountants,  to act as independent
public accountants and to audit the books,  records and accounts for the Company

                                       12
<PAGE>

for the fiscal year ending December 31, 2000. In accordance with a resolution of
the Board,  this  selection  is being  presented to the  stockholders  for their
ratification  at the  Meeting.  The firm of Grant  Thornton  was retained as the
Company's  independent  accountants in November 1997. If the stockholders do not
ratify the selection of Grant Thornton, the selection of independent accountants
will be  reconsidered  by the Board. A  representative  of Grant Thornton is not
expected to be present at the Meeting.

          The  affirmative  vote of the  holders of a majority  of the shares of
Common Stock present at the Meeting,  in person or by proxy, is required for the
ratification of the selection of Grant Thornton.

         THE BOARD UNANIMOUSLY  RECOMMENDS A VOTE "FOR" THE ADOPTION OF PROPOSAL
II.

                                  OTHER MATTERS

          As of the date of this proxy statement,  the Board has no knowledge of
any business  which will be presented for  consideration  at the Meeting,  other
than as described  above.  If any other  matter or matters are properly  brought
before the Meeting or any  adjournment(s)  thereof,  pursuant  to the  Company's
By-laws,  it is the intention of the persons named in the  accompanying  form of
proxy to vote proxies in accordance with their judgment.

                       SUBMISSION OF STOCKHOLDER PROPOSALS

          In  accordance  with the  Company's  By-laws  and Rules  14a-4(c)  and
14a-5(e)  promulgated  under the Exchange Act, the Company  hereby  notifies its
stockholders  that it did not receive  notice by July 25, 2000,  of any proposed
matter to be submitted for stockholder vote at the Meeting, and, therefore,  any
proxies  received in respect of the Meeting will be voted in the  discretion  of
the  Company's  management  on other  matters which may properly come before the
Meeting.

          Any proposal which is intended to be presented by any  stockholder for
action at the 2001 Annual Meeting of Stockholders must be received in writing by
the  Secretary of the Company at 1251 Avenue of the  Americas,  45th Floor,  New
York,  New York  10020-1104,  not  later  than  July 2,  2001 in order  for such
proposal to be considered for inclusion in the Proxy Statement and form of proxy
relating to the 2000 Meeting of Stockholders.

                                       13
<PAGE>

          The Company further notifies its stockholders that if the Company does
not  receive  notice by July 2, 2001 of a proposed  matter to be  submitted  for
stockholders  vote at the 2001 Annual Meeting of Stockholders,  then any proxies
held by members of the  Company's  management  in respect of such Meeting may be
voted at the  discretion of such  management  members on such matter if it shall
properly  come before such  Meeting,  without any  discussion  of such  proposed
matter in the proxy statement to be distributed in respect of such Meeting.

                                   By Order of the Board of Directors

                                   STEPHEN A. OLLENDORFF
                                   Secretary

Dated: October 30, 2000

                                       14

<PAGE>

                               ACORN HOLDING CORP.
                    Proxy for Annual Meeting of Stockholders
                          to be Held December 12, 2000

                 THIS PROXY IS BEING SOLICITED ON BEHALF OF THE
                               BOARD OF DIRECTORS

          The  undersigned  stockholder(s)  of ACORN HOLDING  CORP.,  a Delaware
corporation (the "Company"),  hereby  constitutes and appoints EDWARD N. EPSTEIN
and STEPHEN A. OLLENDORFF,  and each of them, with full power of substitution in
each,  as the agent,  attorneys and proxies of the  undersigned,  for and in the
name, place and stead of the undersigned,  to vote at the 2000 Annual Meeting of
Stockholders  of the  Company to be held at 1251  Avenue of the  Americas,  45th
Floor,  New York, New York 10020-1104 on December 12, 2000, at 11:00 A.M. (local
time),  and any  adjournment(s)  thereof,  all of the shares of stock  which the
undersigned  would be entitled to vote if then personally  present in the manner
specified and on any other business as may properly come before the meeting.

   This Proxy will be voted in accordance  with the  instructions  given.  If no
instructions are given in respect of a Proposal,  this Proxy will be voted "FOR"
such Proposal.

Please mark boxes __ or x in blue or black ink.

1.  ELECTION OF DIRECTORS

FOR all nominees listed below               WITHHOLD AUTHORITY to vote
(except as marked to the                    for all nominees listed
contrary below)             /___/           below                      /___/

                       Paula Berliner, Edward N. Epstein,
                             Ronald J. Manganiello,
                        Stephen A. Ollendorff, Bert Sager

(Instruction: To withhold authority to vote for any individual nominee(s) write
the nominee's name in the space below):


------------------------------------------------------


(Continued and to be signed on the reverse side.)


<PAGE>



2.       RATIFICATION OF THE SELECTION OF THE FIRM OF
         GRANT THORNTON LLP AS THE INDEPENDENT PUBLIC
         ACCOUNTANTS OF THE COMPANY FOR THE 2000 FISCAL YEAR

         FOR _____     AGAINST _____    ABSTAIN _____


         In their  discretion,  the proxies are hereby  authorized  to vote upon
such other  business as may properly come before the meeting or any  adjournment
thereof and as set forth in Rule  14a-4(c)  of the  Securities  Exchange  Act of
1934.

         Please  sign  exactly as name  appears  above.  When shares are held by
joint  tenants,   both  should  sign.   When  signing  as  attorney,   executor,
administrator,  trustee  or  guardian,  please  give  full  title as such.  If a
corporation, please sign in full corporate name by President or other authorized
officer. If a partnership, please sign in partnership name by authorized person.

                              Dated ________________________, 2000

                              ------------------------------------
                                    Signature

                              -----------------------------------
                               Signature if held jointly

                              Title______________________________


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission